N/A N=66 RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)
Peripheral Arterial Disease
Primary: 6-Minute Walk Distance, Meters — -12.8; 4.6; -12.3 meters
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=558 Clinical Study of Real Time Colorectal Polyp Diagnosis During Colonoscopy - the VALID Colonoscopy Study
Colorectal Neoplasm · Colonic Polyps
Primary: Rate of Accurate High Confidence Polyp Histology Predictions by the Endoscopist in the Two Groups. — 75.3; 63.1 Percent of accurate HC predictions
N/A N=50 Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy
Multiple Myeloma · Breast Cancer
Primary: Relative Node Detection Sensitivity — 88.5; 94.2 Percentage (%) of SLNs detected
N/A N=15 Study Performance of The Plexur P™ Bone Void Filler Device in Patients Undergoing Iliac Crest Harvesting Procedures
Iliac Crest Harvesting Procedure-Bone Void Filler
Primary: Number of Participants With Reconstitution of Bone Growth in the Iliac Crest Bone Void Determined by an Independent Radiologist — 11; 4; 0; 0 Participants
Phase 3 N=1,056 A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Major Depressive Disorder
Primary: Change From Randomization to Week 8 in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score — -8.73; -8.49 units on a scale — p=0.751
N/A N=13 [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
Brain Cancer · Gliomas
Primary: Determine & Comp Biodistribution, Clearance, & Dosimetry of [18F]FACBC & [18F]FLT Tissue/Organs w/i the Field of View of the Dynamic PET Imag Studies prior-to & During…
N/A N=25 STimulation to Improve Auditory haLLucinations
Schizophrenia · Schizoaffective Disorder
Primary: Proportional Change From Baseline in Auditory Hallucination Rating Scale (AHRS) Score — 0.85; 0.94; 0.91; 0.84 proportion to baseline — p=0.47
Phase 2 N=571 Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Type 2 Diabetes Mellitus
Primary: Change in HbA1c (%) at 16 Weeks — -0.33; -0.40; -0.49; -0.62 % glycated haemoglobin — p=0.1449
N/A N=100 A Prospective Multi-Center Study of Anterior Lens Capsulotomy Using the Mynosys Zepto System
Cataract
Primary: Complete Capsulotomy — 98 participants
N/A N=339 Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters
Venous Thrombosis
Primary: Evidence of PICC-related Venous Thrombosis — 102; 95 Participants
N/A N=331 Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH Study
Diabetes Mellitus · Hyperglycemia · Obesity
Primary: Percent Change in Body Weight — -0.15; -1.42 percentage of change — p=0.017
Phase 3 N=424 A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1c (HbA1c) at 24 Weeks (Treatment-regimen Estimand) — -1.34; -1.21; -0.54 percentage of HbA1c — p=<.001
N/A N=50 Evaluation of a Tracheostomy Tube That Enables Communication
Evaluate the Effect of a Talking Tracheostomy Tube on Quality of Life
Primary: Change in Quality of Life — 44.65; 42.78; 50.24; 49.41 units on a scale
Phase 2 N=38 Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder
Bipolar Disorder
Primary: NEW Tx Scale — 23.54; 37.75 units on a scale
N/A N=23 Cycling Versus Continuous Mode in Neuromodulator Programming
Urinary Incontinence, Urge
Primary: Overactive Bladder Questionnaire-Short Form (OABq) Short Form Symptom Bother Scale Result — 68.3; 66.3; 30.3; 38.0 units on a scale